A biotech 12 years in the making has secured its largest financing yet, and it has ambitious plans for what the chief executive called a “David vs. Goliath” venture. MinervaX, based out of Copenhagen, put out word bright and early Thursday that it secured €72 million in new funding via both equity financing and a […]